104 related articles for article (PubMed ID: 926201)
21. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
[TBL] [Abstract][Full Text] [Related]
22. Absorption, distribution, excretion and metabolism of orally administered 14C-beta-cyclodextrin in rat.
Gerlóczy A; Fónagy A; Keresztes P; Perlaky L; Szejtli J
Arzneimittelforschung; 1985; 35(7):1042-7. PubMed ID: 4052138
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics of 4-acetylaminophenylacetic acid. 1st communication: absorption, distribution, metabolism and excretion in mice, rats, dogs and monkeys after single administration of 14C-labeled compound.
Sugihara K; Morino A; Nomura A; Iida S; Sugiyama M
Arzneimittelforschung; 1990 Jul; 40(7):800-5. PubMed ID: 2222556
[TBL] [Abstract][Full Text] [Related]
24. NTP technical report on the toxicity studies of p-tert-butylcatechol (CAS No. 98-29-3) administered in feed to F344/N rats and B6C3F1 mice.
Dunnick J
Toxic Rep Ser; 2002 Nov; (70):5-51. PubMed ID: 12592414
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics and metabolism of the new thromboxane A2 receptor antagonist ramatroban in animals. 2nd communication: distribution to organs and tissues in male, female and pregnant rats, and characteristics of protein binding in plasma.
Steinke W; Ahr HJ; Hirayama M
Arzneimittelforschung; 1997 Aug; 47(8):939-48. PubMed ID: 9296280
[TBL] [Abstract][Full Text] [Related]
26. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl] benzoic acid. 2nd communication: absorption, distribution and excretion after single and consecutive subcutaneous administration in rats.
Mizojiri K; Okabe H; Sugeno K; Esumi Y; Takaichi M; Tsutsumi S; Harada T; Miyoshi R; Inaba A
Arzneimittelforschung; 1997 Feb; 47(2):195-200. PubMed ID: 9079240
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics of ciprofloxacin. 2nd communication: distribution to and elimination from tissues and organs following single or repeated administration of [14C]ciprofloxacin in albino rats.
Siefert HM; Maruhn D; Scholl H
Arzneimittelforschung; 1986 Oct; 36(10):1503-10. PubMed ID: 3101707
[TBL] [Abstract][Full Text] [Related]
28. Pre-clinical pharmacokinetics of the cyclooxygenase-inhibiting nitric oxide donor (CINOD) AZD3582.
Fagerholm U; Breuer O; Swedmark S; Hoogstraate J
J Pharm Pharmacol; 2005 May; 57(5):587-97. PubMed ID: 15901348
[TBL] [Abstract][Full Text] [Related]
29. Whole body autoradiographic and quantitative tissue distribution studies with 14C-cefotaxime in the rat.
Stevens LA; Ings RM; Fromson JM; Coombes JD
Arzneimittelforschung; 1984; 34(12):1723-9. PubMed ID: 6099126
[TBL] [Abstract][Full Text] [Related]
30. Absorption, distribution and excretion of 2,4-diamino-6-(2,5-dichlorophenyl)-s-triazine maleate in rats, dogs and monkeys.
Ando T; Momota K; Sugiyama M
Arzneimittelforschung; 1986 Aug; 36(8):1221-8. PubMed ID: 3778559
[TBL] [Abstract][Full Text] [Related]
31. Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys.
Vincent SH; Painter SK; Krieter PA; Colletti AE; Lyszack E; Rosegay A; Dean D; Luffer-Atlas D; Miller RR; Cioffe C; Chiu SH
Drug Metab Dispos; 1996 Dec; 24(12):1369-77. PubMed ID: 8971144
[TBL] [Abstract][Full Text] [Related]
32. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
Marsman D
Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
[TBL] [Abstract][Full Text] [Related]
33. Disposition of 14C-alpha-cyclodextrin in germ-free and conventional rats.
Van Ommen B; De Bie AT; Bär A
Regul Toxicol Pharmacol; 2004 Jun; 39 Suppl 1():57-66. PubMed ID: 15265616
[TBL] [Abstract][Full Text] [Related]
34. Disposition of benzo(f)quinoline in male rats.
Birnbaum LS; Johnson L
Drug Metab Dispos; 1985; 13(1):18-24. PubMed ID: 2858371
[TBL] [Abstract][Full Text] [Related]
35. Absorption and excretion of suprofen in rats.
Mori Y; Yokoya F; Toyoshi K; Baba S; Sakai Y
Drug Metab Dispos; 1983; 11(4):387-91. PubMed ID: 6137348
[TBL] [Abstract][Full Text] [Related]
36. Effects of dose, strain, and dosing vehicle on methacrylonitrile disposition in rats and identification of a novel-exhaled metabolite.
Ghanayem BI; Sanchez IM; Burka LT
Drug Metab Dispos; 1992; 20(5):643-52. PubMed ID: 1358567
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics of prulifloxacin. 1st communication: absorption, distribution and excretion in rats, dogs and monkeys after a single administration.
Okuyama Y; Momota K; Morino A
Arzneimittelforschung; 1997 Mar; 47(3):276-84. PubMed ID: 9105546
[TBL] [Abstract][Full Text] [Related]
38. Toxicokinetics of allynitrile in rats.
Farooqui MY; Ybarra B; Piper J
Drug Metab Dispos; 1993; 21(3):460-6. PubMed ID: 8100502
[TBL] [Abstract][Full Text] [Related]
39. [Absorption, distribution, excretion and metabolism of a basic ether compound (R97) with antispasmodic activity].
Matsuda H; Kawaba T; Yamamoto Y; Ogawa S
Nihon Yakurigaku Zasshi; 1976 Sep; 72(6):657-72. PubMed ID: 1034592
[TBL] [Abstract][Full Text] [Related]
40. Disposition and metabolism of [14C]dibenzo[c,g]carbazole aerosols in rats after inhalation.
Bond JA; Ayres PH; Medinsky MA; Cheng YS; Hirshfield D; McClellan RO
Fundam Appl Toxicol; 1986 Jul; 7(1):76-85. PubMed ID: 3732674
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
